Company Valuation: Shanghai Runda Medical Technology Co., Ltd.

Data adjusted to current consolidation scope
Fiscal Period: December 2020 2021 2022 2023 2024 2025
Market Cap 1 6,479 7,772 5,859 11,923 9,540 9,025
Change - 19.95% -24.61% 103.5% -19.99% -5.4%
Enterprise Value (EV) 1 9,989 12,421 11,591 17,548 15,297 14,744
Change - 24.35% -6.68% 51.39% -12.83% -3.62%
P/E 19.6x 21x 14.4x 43.3x 177x -16.4x
PBR 2.02x 2.24x 1.51x 2.84x 2.21x 2.38x
PEG - 1.7x 1.54x -1.3x -2.2x 0x
Capitalization / Revenue 0.92x 0.88x 0.56x 1.3x 1.15x 1.29x
EV / Revenue 1.41x 1.4x 1.1x 1.92x 1.84x 2.11x
EV / EBITDA 9.73x 10.1x 9.11x 17.1x 17.5x 51.1x
EV / EBIT 13.6x 13.1x 11.8x 24.2x 27.5x 9,083x
EV / FCF -9.56x -21.9x -11.4x 77.7x 60.5x 27.8x
FCF Yield -10.5% -4.57% -8.78% 1.29% 1.65% 3.59%
Dividend per Share 2 0.114 - 0.15 0.1 0.03 -
Rate of return 1.02% - 1.48% 0.49% 0.19% -
EPS 2 0.57 0.64 0.7 0.47 0.09 -0.91
Distribution rate 20% - 21.4% 21.3% 33.3% -
Net sales 1 7,069 8,860 10,494 9,147 8,312 6,999
EBITDA 1 1,026 1,227 1,272 1,024 872.9 288.3
EBIT 1 735 949.2 978.5 723.9 556.1 1.623
Net income 1 330 380.2 417.7 273.3 55.28 -548.4
Net Debt 1 3,510 4,649 5,732 5,625 5,757 5,719
Reference price 2 11.180 13.410 10.110 20.350 15.930 14.950
Nbr of stocks (in thousands) 579,534 579,538 579,543 585,914 598,876 603,676
Announcement Date 4/26/21 4/26/22 4/25/23 4/26/24 4/25/25 4/28/26
1CNY in Million2CNY
Estimates

P/E (Y) EV / Sales (Y) EV / EBITDA (Y) Dividend Yield (Y) Capi.($)
- - - - 863M
-53.48x16.1x-117.84x-.--% 20.67B
17.47x1.98x8.26x1.48% 9.85B
23.75x4.49x12.65x - 7B
-54.83x8.42x-71.65x-.--% 5.55B
19.33x6.63x14.99x2.98% 5.23B
167.7x4.2x27.48x-.--% 4.66B
20.33x3.57x11.09x1.87% 4.2B
16.62x - - 3.86% 2.72B
Average 19.61x 6.48x -16.43x 1.45% 6.75B
Weighted average by Cap. -0.97x 8.74x -42.15x 0.92%

Y-o-Y evolution of P/E

Historical PBR trend

Evolution Enterprise Value / Sales

Change in Enterprise Value/EBITDA

  1. Stock Market
  2. Stocks
  3. 603108 Stock
  4. Valuation Shanghai Runda Medical Technology Co., Ltd.